Ca 2+/calmodulin-dependent protein kinase II function in vascular remodelling

Journal of Physiology

Volumn 590, Issue 6, 2012, Pages 1349-1356

  Singer, Harold A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GAMMA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 2A; ISOENZYME; MESSENGER RNA; UNCLASSIFIED DRUG; CALCIUM;

ANGIOGENESIS; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA GENE; CALCIUM SIGNALING; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SWITCHING; GENETIC TRANSCRIPTION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; VASCULAR SMOOTH MUSCLE; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; MUSCLE, SMOOTH, VASCULAR; TRANSCRIPTION, GENETIC;

EID: 84858168177     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.222232     Document Type: Review

References (55)

1. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle. J Biol Chem 271, 2506-2513.
2. Abraham ST, Benscoter HA, Schworer CM & Singer HA (1997). A role for CaM kinase II in the MAP kinase signaling cascade in cultured rat aortic vascular smooth muscle cells. Circ Res 81, 575-584.
3. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS & Olson EN (2009). The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 106, 2342-2347.
4. Backs J, Song K, Bezprozvannaya S, Chang S & Olson EN (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116, 1853-1864.
5. Backs J, Stein P, Backs T, Duncan FE, Grueter CE, McAnally J, Qi X, Schultz RM & Olson EN (2010). The gamma isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption. Proc Natl Acad Sci U S A 107, 81-86.
6. Barlow CA, Rose P, Pulver-Kaste RA & Lounsbury KM (2006). Excitation-transcription coupling in smooth muscle. J Physiol 570, 59-64.
7. Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF, Barroso M, Singer HA, Jourd'heuil D & Trebak M (2010). Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol Cell Physiol 298, C993-1005.
8. Creemers EE, Sutherland LB, McAnally J, Richardson JA & Olson EN (2006). Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133, 4245-4256.
9. Dolmetsch R (2003). Excitation-transcription coupling: signaling by ion channels to the nucleus. Sci STKE 2003, E4.
10. Dosemeci A & Albers RW (1996). A mechanism for synaptic frequency detection through autophosporylation of CaM kinase II. Biophys J 70, 2493-2501.
11. Easley CA, Brown CM, Horwitz AF & Tombes RM (2008). CaMK-II promotes focal adhesion turnover and cell motility by inducing tyrosine dephosphorylation of FAK and paxillin. Cell Motil Cytoskeleton 65, 662-674.
12. Erickson JR, He BJ, Grumbach IM & Anderson ME (2011). CaMKII in the cardiovascular system: sensing redox states. Physiol Rev 91, 889-915.
13. Firulli AB, Miano JM, Bi W, Johnson AD, Casscells W, Olson EN & Schwarz JJ (1996). Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype. Circ Res 78, 196-204.
14. Gangopadhyay SS, Barber AL, Gallant C, Grabarek Z, Smith JL & Morgan KG (2003). Differential functional properties of calmodulin-dependent protein kinase IIγ variants isolated from smooth muscle. Biochem J 372, 347-357.
15. Ginnan R & Singer HA (2002). CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 282, C754-C761.
16. Gordon JW, Pagiatakis C, Salma J, Du M, Andreucci JJ, Zhao J, Hou G, Perry RL, Dan Q, Courtman D, Bendeck MP & McDermott JC (2009). Protein kinase A-regulated assembly of a MEF2/HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J Biol Chem 284, 19027-19042.
17. 2+/calmodulin-dependent protein kinase II blocks its nuclear targeting. J Biol Chem 273, 19763-19771.
18. House SJ, Ginnan RG, Armstrong SE & Singer HA (2007). Calcium/calmodulin-dependent protein kinase II-δ isoform regulation of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 292, C2276-C2287.
19. House SJ, Potier M, Bisaillon J, Singer HA & Trebak M (2008a). The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456, 769-785.
20. House SJ & Singer HA (2008). CaMKII-δ isoform regulation of neointima formation after vascular injury. Arterioscler Thromb Vasc Biol 28, 441-447.
21. 2+/calmodulin-dependent protein kinase II signaling in vascular smooth muscle. In Advances in Biochemistry in Health and Disease: Signal Transduction in the Cardiovascular System in Health and Disease, ed. Srivastava AK & Srivastava MB, pp. 521-549. Springer.
22. 2+/calmodulin-dependent protein kinase II: The role of structure and autoregulation in cellular function. Annu Rev Biochem 71, 473-510.
23. Kim HR, Appel S, Vetterkind S, Gangopadhyay SS & Morgan KG (2008). Smooth muscle signalling pathways in health and disease. J Cell Mol Med 12, 2165-2180.
24. 2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol 526, 367-374.
25. Li H, Li W, Gupta AK, Mohler PJ, Anderson ME & Grumbach IM (2010). Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. Am J Physiol Heart Circ Physiol 298, H688-H698.
26. 2+/calmodulin-dependent kinase II δ (CaMKIIδ) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle regulation by p21. J Biol Chem 286, 7990-7999.
27. 2+ signaling and control of growth and proliferation. Biol Cell 96, 55-68.
28. Lu KK, Armstrong SE, Ginnan R & Singer HA (2005). Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol 289, C1343-C1350.
29. 2+/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells. Circ Res 97, 541-549.
30. 2+/calmodulin-dependent protein kinase II with neuronal cytoskeletal proteins. Characterization of binding to a 190-kDa postsynaptic density protein. J Biol Chem 270, 10043-10049.
31. Mercure MZ, Ginnan R & Singer HA (2008). CaM kinase II δ2-dependent regulation of vascular smooth muscle cell polarization and migration. Am J Physiol Cell Physiol 294, C1465-C1475.
32. Meyer T, Hanson PI, Stryer L & Schulman H (1992). Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 256, 1199-1202.
33. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR & Malik KU (1998). 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci U S A 95, 12701-12706.
34. Owens GK, Kumar MS & Wamhoff BR (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767-801.
35. Pang J, Yan C, Natarajan K, Cavet ME, Massett MP, Yin G & Berk BC (2008). GIT1 mediates HDAC5 activation by angiotensin II in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28, 892-898.
36. Pauly PR, Bilato C, Sollott SJ, Monticone R, Kelly PT, Lakatta EG & Crow MT (1995). Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circ Res 91, 1107-1115.
37. Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA & Trebak M (2009). Evidence for Stim1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23, 2425-2437.
38. 2+ source-dependent transcription of CRE-containing genes in vascular smooth muscle. Am J Physiol Heart Circ Physiol 291, H97-105.
39. Rokolya A & Singer HA (2000). Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am J Physiol Cell Physiol 278, C537-C545.
40. 2+/CaM kinase II. FEBS J 273, 682-694.
41. Schauer IE, Knaub LA, Lloyd M, Watson PA, Gliwa C, Lewis KE, Chait A, Klemm DJ, Gunter JM, Bouchard R, McDonald TO, O'Brien KD & Reusch JE (2010). CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler Thromb Vasc Biol 30, 733-741.
42. 2+/calmodulin-dependent protein kinase II. Differential expression in rat brain and aorta. J Biol Chem 268, 14443-14449.
43. 2+/calmodulin-dependent protein kinase II γ-subunit variants expressed in vascular smooth muscle, brain and cardiomyocytes. J Biol Chem 272, 9393-9400.
44. Skelding KA, Rostas JA & Verrills NM (2011). Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II. Cell Cycle 10, 631-639.
45. Soderling TR & Stull JT (2001). Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev 101, 2341-2352.
46. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev 8, 2527-2539.
47. Tokunou T, Ichiki T, Takeda K, Funakoshi Y, Iino N & Takeshita A (2001). cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21, 1764-1769.
48. 3 isoform) contains a proline-rich tandem repeat in the association domain. FEBS Lett 358, 23-26.
49. Wamhoff BR, Bowles DK & Owens GK (2006). Excitation-transcription coupling in arterial smooth muscle. Circ Res 98, 868-878.
50. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT & Horwitz AF (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6, 154-161.
51. Wu X, Spiro C, Owen WG & McMurray CT (1998). cAMP response element-binding protein monomers cooperatively assemble to form dimers on DNA. J Biol Chem 273, 20820-20827.
52. Xu X, Ha CH, Wong C, Wang W, Hausser A, Pfizenmaier K, Olson EN, McKinsey TA & Jin ZG (2007). Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler Thromb Vasc Biol 27, 2355-2362.
53. Zhang S, Yang Y, Kone BC, Allen JC & Kahn AM (2003). Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II. Circulation 107, 1539-1544.
54. Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N, Chang S, Ling H, Bers DM, Maier LS, Olson EN & Brown JH (2007). CaMKIIδ isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282, 35078-35087.
55. CRAC is essential for neointima formation after vascular injury. Circ Res 109, 534-542.